We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nonsurgical Options for Cervical Cancer

By HospiMedica staff writers
Posted on 29 Mar 2005
Advances in the treatment options for diseases associated with the human papillomavirus (HPV) include nonsurgical options such as vaccines and chemoprevention.

Previously, the standard treatment has been to surgically remove the infected tissue, which puts some patients at risk for reproductive consequences and does not ensure that all infected tissue has been eliminated. More...
Methods such as chemoprevention and vaccines eliminate these risks and present possible cures without invasive means.

Chemoprevention involves the use of micronutrients or pharmaceutical agents to delay or prevent the development of cancer from HPV in healthy patients. Treatment of infected tissues can be monitored through colposcopy, which is relatively noninvasive, since the cervix is readily available. Two different types of vaccines are being used. One is a prophylactic vaccine that focuses on human immune responses to help prevent HPV infection. The other vaccine is a therapeutic vaccine that stimulates the immune response to eliminate cells already infected.

While surgery has been the standard treatment for HPV-related disease to date, researchers comment that other viral diseases are not treated that way. New research underway is reviewing treatments in order to make further advances in nonsurgical options.

The study was authored by Maria C. Bell, M.D., associate professor in the department of obstetrics and gynecology at the University of South Dakota School of Medicine (Vermillion, USA). The study was published in the March 2005 issue of the International Journal of Gynecological Cancer




Related Links:
of South Dakota School of Medicine

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.